Blood test-guided care for people hospitalized with heart failure
Part of Heart & circulation clinical trials.
This study checks whether using a specific blood test (called sST-2) to guide heart-failure treatment leads to better care and outcomes. It may help by tailoring treatment decisions based on your test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently hospitalized for heart failure
- Your blood work shows heart failure markers are high (NT-proBNP ≥450 or BNP ≥400)
- You must be able to speak fluent French and give informed consent
- You should not be pregnant
- You should not be in another research study at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a simple blood test (NT-proBNP) to find heart failure early in people who have symptoms but haven't been diagnosed yet. If the test levels are high, it could help doctors start treatment sooner.
This study looks at how “personalized” (precision) treatment planning for heart failure may work, using results from heart imaging (echocardiogram) or a blood test called B-type natriuretic peptide. You may join if you have heart failure and can follow frequent study check-ins.
This study looks at certain proteins in your blood to help doctors better understand and diagnose a type of heart failure called HFpEF. You might be able to join if your doctor recently ordered a blood test for NT-proBNP because they thought you might have heart failure.
This study checks whether short-term follow-up blood test results after you leave the hospital can predict how you do with heart failure. It may help doctors choose better follow-up and treatment plans based on your early test trends.
This trial tests whether simple screening using a blood test (natriuretic peptides) plus an ultrasound of the heart (echocardiogram) can find early heart failure sooner. Finding it earlier may help doctors start the right management to prevent it from getting worse.
This study looks at whether a blood test called BNP can help predict what happens over time in people being evaluated for advanced heart failure treatment. It may help doctors better plan care and follow-up for patients long-term.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.